"Voriconazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A.
| Descriptor ID |
D065819
|
| MeSH Number(s) |
D03.383.129.799.950
|
| Concept/Terms |
UK 109,496- UK 109,496
- UK-109,496
- UK109,496
- UK-109496
- UK109496
- UK 109496
|
Below are MeSH descriptors whose meaning is more general than "Voriconazole".
Below are MeSH descriptors whose meaning is more specific than "Voriconazole".
This graph shows the total number of publications written about "Voriconazole" by people in this website by year, and whether "Voriconazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 1 | 3 |
| 2021 | 0 | 1 | 1 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Voriconazole" by people in Profiles.
-
Trichosporonosis in Pediatric Patients With a Hematologic Disorder. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):199-204.
-
Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies. Mycoses. 2014 Nov; 57(11):687-98.
-
Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations. Infection. 2013 Jun; 41(3):723-6.
-
Ulcerated plaque under a ruby ring in an immunosuppressed patient. Dermatol Online J. 2010 Aug 15; 16(8):4.
-
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Support Care Cancer. 2011 Jan; 19(1):19-26.
-
Breakthrough zygomycosis and voriconazole. J Infect Dis. 2005 Oct 15; 192(8):1496-7; author reply 1497.
-
Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors. Antimicrob Agents Chemother. 2005 Feb; 49(2):518-24.
-
Aspergillus fumigatus septic arthritis complicating intra-articular corticosteroid injection. Mayo Clin Proc. 2004 Apr; 79(4):578-9.